Over the last several years, “lured by the prospect of a large untapped global RSV vaccine market,” four manufacturers set their sights on #RSV #vaccine development for infants, pregnant women and the elderly.
#TheDefender
https://childrenshealthdefense.org/defender/pfizer-rsv-vaccine-guillain-barre-syndrome-older-adults/